Cancer treatment using CRISPR-based Genome Editing System Reporter: Irina Robu, PhD CRISPR, stands for “clusters of regularly interspaced short palindromic repeats” is one of the biggest accomplishments in science of this decade and it is the simplest tool for altering DNA sequences and modifying gene functions. The technology is adapted form the natural defense mechanism […]
Search Results for 'CRISPR'
From AAAS Science News on COVID19: New CRISPR based diagnostic may shorten testing time to 5 minutes
Posted in Biomarkers: Inflammation, Cancer Researchers Fighting COVID-19, Coronavirus Gene Expression, COVID-19, COVID-19, COVID-19: Pandemic Surgery Guidance, CRISPR/Cas9 & Gene Editing, Population genetics, Population Health Management, Population Health Management, Genetics & Pharmaceutical, SAR-Cov-2 a vasculotropic (blood vessels) RNA Virus, SARS-CoV-2, Seasonality & Environmental Factors in Resurgence, Treatment Protocols for COVID-19, Virus Infective Acute Respiratory Syndrome: SARS-CoV, tagged #COVID-19, AAAS, coronavirus, CRISPR, CRISPR –Cas9 system for genetic engineering, CRISPR/Cas and crispr, Jennifer Doudna, Molecular Diagnostics, rapid testing, SARS-CoV-2, SARS-CoV-2 Entry Factors, Single-molecule detection, Virus Infective Acute Respiratory Syndrome: SARS-CoV | Tagged COVID-19 on October 11, 2020| Leave a Comment »
From AAAS Science News on COVID19: New CRISPR based diagnostic may shorten testing time to 5 minutes Reporter: Stephen J. Williams, Ph.D. A new CRISPR-based diagnostic could shorten wait times for coronavirus tests. New test detects coronavirus in just 5 minutes By Robert F. ServiceOct. […]
Novartis uses a ‘dimmer switch’ medication to fine-tune gene therapy candidates
Posted in Alzheimer's Disease, Biomarkers & Medical Diagnostics, Cerebrovascular and Neurodegenerative Diseases, CRISPR alternative for editing genes without cutting, CRISPR applied to Human Germ Line, CRISPR/Cas9 & Gene Editing, Etiology, Gene Therapy & Gene Editing Development, Genome Biology, Genomic Expression, Neurodegenerative Diseases, Open Access Journals, RNA Biology, Scientific Publishing, tagged Alternate splicing, Chronic renal disease, CRISPR-Cas9, gene therapy, Huntington's disease, Spinal muscular atrophy on August 7, 2021| 1 Comment »
Novartis uses a ‘dimmer switch’ medication to fine-tune gene therapy candidates Reporter: Amandeep Kaur, BSc., MSc. Using viral vectors, lipid nanoparticles, and other technologies, significant progress has been achieved in refining the delivery of gene treatments. However, modifications to the cargo itself are still needed to increase safety and efficacy by better controlling gene expression. […]
Prime Editing as a New CRISPR Tool to Enhance Precision and Versatility
Posted in CAR-T, CRISPR applied to Human Germ Line, CRISPR/Cas9 & Gene Editing, Disease Biology, Gene Therapy & Gene Editing Development, Genetics & Innovations in Treatment, Genome Biology, tagged Broad Institute, CRISPR, CRISPR –Cas9 system for genetic engineering, CRISPR-based gene editing, Editas, gene editing technology platform, genetic engineering, Nature, off target effects, Tay-Sachs on August 29, 2020| 1 Comment »
Prime Editing as a New CRISPR Tool to Enhance Precision and Versatility Reporter: Stephen J. Williams, PhD CRISPR has become a powerful molecular for the editing of genomes tool in research, drug discovery, and the clinic (see posts and ebook on this site below) Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene […]
The Nobel Prize in Chemistry 2020: Emmanuelle Charpentier & Jennifer A. Doudna
Posted in Award Nominations, Cell Biology, CRISPR alternative for editing genes without cutting, CRISPR applied to Human Germ Line, CRISPR/Cas9 & Gene Editing, DNA repair, Gene Therapy & Gene Editing Development, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genome Biology, Interviews with Key Opinion Leaders (KOLs), Molecular Genetics & Pharmaceutical, Nobel Prize WInners, Stem Cells for Regenerative Medicine, tagged CRISPR –Cas9 system for genetic engineering, CRISPR Biology • Genome Editing • Gene Drives • DNA Repair • Model and Industrial Organisms • Technology Development • Stem Cells/Cancer • Genome-Wide Screens, CRISPR-based gene editing, CRISPR-Cas9, CRISPR/Cas and base editing, gene editing, gene editing technology platform, Jennifer Doudna, nobel leureates, Nobel Prize, Nobel Prize in Chemistry, Stanford University on October 8, 2020| 1 Comment »
The Nobel Prize in Chemistry 2020: Emmanuelle Charpentier & Jennifer A. Doudna Reporters: Stephen J. Williams, Ph.D. and Aviva Lev-Ari, PhD, RN The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2020 to Emmanuelle CharpentierMax Planck Unit for the Science of Pathogens, Berlin, Germany Jennifer A. DoudnaUniversity of California, Berkeley, […]
CRISPR-Cas9 and the Power of Butterfly Gene Editing
Posted in Behavioral Genetics, CRISPR alternative for editing genes without cutting, CRISPR/Cas9 & Gene Editing, Genome Biology, Microbiologial genetics, Transcriptomics on August 23, 2020| Leave a Comment »
CRISPR-Cas9 and the Power of Butterfly Gene Editing Reporter: Madison Davis Genome editing is a relatively new branch of genetic engineering that utilizes modern technologies in altering, inserting, or deleting selective DNA sequences within cells. CRISPR-Cas9, otherwise known as “Clustered Regularly Interspaced Short Palindromic Repeat”, is a groundbreaking genome editing technique for scientists, as it […]
CRISPR Cuts Turn Gels into Biological Watchdogs
Posted in CRISPR/Cas9 & Gene Editing, tagged Cas12a, CRISPR, CRISPR-based gene editing, human genome, hydrogel on August 30, 2019| Leave a Comment »
Update 6/11/2020 CRISPR-IL used to develop next-gen genome editing products Haifa-based Pluristem Therapeutics is a regenerative medicine company that plans to develop next-generation multi-species genome editing products for human, plant and animal DNA that could improve work done in the pharma, agriculture and aquaculture industries. The CRISPR-IL consortium includes Sheba Medical Center and Schneider Children’s Medical […]
Follow Blog via Email
Join 1,999 other subscribers-
Recent Posts
- Near Term Investment Outlook for 2023: A Perspective from Advisors Potentially Affecting M&A Landscape August 5, 2022
- SOP for production of WordClouds for articles in the NEW GENRE Audio English-Spanish: BioMed e-Series – 18 Volumes in Medicine July 25, 2022
- Cardiothoracic surgeons at UC San Francisco performed the first robotically assisted mitral valve prolapse surgery in San Francisco. July 22, 2022
- Explanation on “Results of Medical Text Analysis with Natural Language Processing (NLP) presented in LPBI Group’s NEW GENRE Edition: NLP” on Genomics content, standalone volume in Series B and NLP on Cancer content as Part B New Genre Volume 1 in Series C July 7, 2022
- Sperm damage and fertility problem due to COVID-19 June 23, 2022
- Genomic data can predict miscarriage and IVF failure June 15, 2022
- The Human Genome Gets Fully Sequenced: A Simplistic Take on Century Long Effort June 14, 2022
- Aortic Valve Transplant Via Carotid Artery at Hadassah – An Israel First May 29, 2022
- Omecamtiv mecarbil – A study examined efficacy and tolerability in Heart Failure patients with SBP ≤100 mmHg enrolled in GALACTIC-HF May 23, 2022
- Sperm epigenetic clock and pregnancy outcomes May 14, 2022
Archives
Categories
Meta
-
2012pharmaceutical
-
Amandeep Kaur
-
Aashir Awan, Phd
-
Abhisar Anand
-
Adina Hazan
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
dsmolyar
-
Ethan Coomber
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jayzmit48
-
jdpmd
-
jshertok
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
Madison Davis
-
marzankhan
-
megbaker58
-
ofermar2020
-
Dr. Pati
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
Srinivas Sriram
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
vaishnavee24
-
zraviv06
-
zs22
-
